comparemela.com

Page 9 - Huntington Potter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global Down Syndrome Foundation Funding For Alzheimer s Research Results In Milestone Clinical Trial For People With Down Syndrome

Study Identifies Cytokines That Predict Cognitive Trajectories in Older Adults

Study Identifies Cytokines That Predict Cognitive Trajectories in Older Adults
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

What you need to know about the FDA-approved drug for Alzheimer s

What you need to know about the FDA-approved drug for Alzheimer s By: Newsy and last updated 2021-06-09 09:38:59-04 It s the first FDA-approved drug for Alzheimer s in nearly 20 years.  Usually FDA-approved drugs are covered by insurance and Medicare and Medicaid, said Dr. Huntington Potter, the director of the University of Colorado Alzheimer s and Cognition Center.  But questions linger about whether it actually works, and if health insurance companies will even front the estimated annual cost of $56,000 a year.  The first thing to do is to talk to their regular primary care physician, Potter said.  The drug in question is called Aducanumab, or Aduhelm. According to the latest study, the drug slows cognitive decline by 22%. Experts say this isn t enough, but the FDA and Alzheimer s Association believe it s worth a shot.  

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.